Storage-stable ready-to-use formulations of tigecycline
US11654151B2 · kind B2 · utility
0Cited by
0References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 21, 2020 |
| Grant date | May 23, 2023 |
| Priority date | — |
| Expiry date | May 10, 2041 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/52
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Liquid parenteral formulations are provided that include tigecycline and at least one or more pharmaceutically acceptable excipient or adjuvant, where the formulation is ready to use without additional steps for reconstitution at the time of administration.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.